Lataa...
Somatostatin analogues labeled with copper radioisotopes: current status
Peptide receptor radionuclide therapy (PRRT) is a promising way to treat patients with inoperable tumors or metastatic neuroendocrine tumors. This therapeutic strategy is using radiolabeled peptides, which are capable of selective biding to receptors overexpressed in the cancer cells. One of the gro...
Tallennettuna:
| Julkaisussa: | J Radioanal Nucl Chem |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Netherlands
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5533839/ https://ncbi.nlm.nih.gov/pubmed/28804185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10967-017-5323-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|